温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.poz.com/tag/adherence
点击访问原文链接

adherence - POZ

进入原网站 导航首页
POZ DirectoryMy AccountHomeBasicsBasicsIntroductionHIV Transmission and RisksHIV TestingHIV PreventionNewly DiagnosedStarting HIV TreatmentHIV MedicationsHIV Drug Assistance ProgramsOther Related ConditionsVIH/SIDA en EspañolNewsNewsNewsfeedScience NewsFeaturesOpinionsConferencesSlideshowsVideosPOZ at HomePOZ TVPOZ StoriesPOZ 100By AuthorRSS LinksHot TopicsHot TopicsPOZ AwardsWorld AIDS DayCriminalizationCureLong-Term SurvivorsNewly DiagnosedPrEPPreventionUndetectable (U=U)YouthMagazineMagazineCurrent IssueArchivesDigital EditionsPOZ FocusPOZ en EspañolSubscriptionsEmail NewslettersBlogsBlogsRecent PostsBrowse BloggersRSS LinksCommunityCommunityPOZ PersonalsPOZ StoriesPOZ 100CommunityAIDS Is EverydayForumsPollsSurveysQuizzesAsk POZAwareness DaysServices DirectoryCalendarJobsBookstoreAbout UsAbout UsAbout UsMastheadAwardsPress ReleasesAdvertiseContact UsSmart + StrongTerms of useYour privacySmart + StrongSmart + StrongTerms of useYour privacySmart + StrongSunlenca Pills Can Bridge Gaps When Injections Are MissedAre Injectables Feasible for People Without Viral Suppression?HIV Treatment Adherence 101Sunlenca Pills Can Bridge Gaps When Injections Are MissedAre Injectables Feasible for People Without Viral Suppression?HIV Treatment Adherence 101Caring for Communities: Pharmacists’ Role in HIV Care and PreventionPharmacists are playing a key role in expanding access to HIV services, especially in areas with limited access to traditional health care.Florida Judge to Hear Challenge That Would Stop Cuts to AIDS Drug Assistance ProgramAIDS Healthcare Foundation’s legal petition may help over 16,000 Floridians on ADAP keep their access to HIV meds and services.Lenacapavir Resistance Comes at a Cost to HIV FitnessHIV can evolve to evade the long-acting antiretroviral, but such mutations impair its ability to replicate efficiently.Meet Monique Carry, a New Leading Voice in the Global HIV Movement U=UU=U reminds us that ending the HIV epidemic happens when we pair biomedical advances with truth and compassion, says PAC’s Monique Carry.POZ Poll: Do you expect the new year will be better for you than 2025?Weekly Oral HIV Treatment Looks Good at Two YearsA once-weekly combination of lenacapavir and islatravir pills maintained viral suppression for 96 weeks.How Three Friends Came Together to Help Men Living with HIV [SPONSORED]Understanding Your Lab WorkSwitching HIV TreatmentOver 90% of Clients in the Ryan White HIV/AIDS Program Reach Undetectable StatusNew data confirm Ryan White’s success—undetectable equals untransmittable, and healthier—but GOP leaders want to slash these HIV funds.Lenacapavir PrEP Does Not Interfere With Hormone Therapy for Trans PeopleLevels of feminizing and masculinizing hormones remained generally comparable before and after lenacapavir administration.Bictegravir/Lenacapavir Daily Combo Pill Maintains HIV SuppressionThe two-drug single-tablet regimen could simplify treatment for people currently on complex regimens.Twice-Yearly Lenacapavir Could Be an Option for Initial HIV TreatmentThe long-acting injectable antiretroviral helps maintain long-term viral suppression, but it still needs equally durable partners.WHO Releases Updated Guideline on HIV Service DeliveryGuideline recommends integrating diabetes, high blood pressure and mental health care into HIV services.Cabenuva Can Be an Option for People Without Viral SuppressionMost people who started the long-acting injectables with a detectable viral load were able to bring their HIV under control.Intermittent Antiretroviral Therapy Can Work as Well as Daily TreatmentTaking medications three to five days a week could stretch limited drug supplies due to global funding cuts.Biktarvy Granted New Indication for HIV TreatmentThe single-tablet regimen may now be prescribed for previously treated people without viral suppression.Ulonivirine Shows Promise for Weekly Oral HIV TreatmentStudy was halted early, but the novel NNRTI is now being tested with a lower dose of islatravir.Racial Disparities in HIV Care Retention PersistA study of South Carolina HIV data emphasizes the need for equitable access to care to help end the U.S. epidemic.People With HIV Fare as Well as Those Without After Liver TransplantsPipeline Drugs Could Allow for Twice-Yearly HIV TreatmentDoravirine/Islatravir Combo Pill Could Soon Be a New HIV Treatment OptionBroadly Neutralizing Antibody Helps Maintains Viral SuppressionBictegravir/Lenacapavir Combo Pill Could Replace Complex HIV TreatmentSupplements Don’t Prevent Cancer, Studies ShowTrump’s Cuts to Medicaid Threaten Services That Help Disabled People Live at HomeState Lawmakers Seek Restraints on Wage Garnishment for Medical DebtThe Promise: A Final Interview With Butch McKayWhen It Comes to Health Insurance, Federal Dollars Support More Than ACA PlansClick hereOur Privacy PolicyManagePrivacy PolicyCookie Usage

智能索引记录